Hemlibra
Payments companies reported to CMS as associated with Hemlibra. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Hemlibra, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Hemlibra
These are the largest totals companies reported as associated with Hemlibra. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Guy Young | Bozeman, MT | Pediatric Hematology-Oncology | $40,410.06 |
| Maya Bloomberg | Miami, FL | Nurse Practitioner | $39,105.06 |
| Angela Weyand | Ann Arbor, MI | Pediatric Hematology-Oncology | $34,301.03 |
| Tammuella Chrisentery-Singleton | New Orleans, LA | Pediatric Hematology-Oncology | $30,570.99 |
| Lynn Malec | Milwaukee, WI | Pediatric Hematology-Oncology | $27,224.15 |
| Courtney Thornburg | San Diego, CA | Pediatric Hematology-Oncology | $25,026.70 |
| Christopher Walsh | New York, NY | Hematology & Oncology | $24,743.39 |
| Michael Recht | New Haven, CT | Pediatric Hematology-Oncology | $24,236.92 |
| Ellis Neufeld | Memphis, TN | Pediatric Hematology-Oncology | $23,989.71 |
| Michael Silvey | Kansas City, MO | Pediatric Hematology-Oncology | $22,362.59 |
Prescribed Hemlibra?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.